Funding boost for GSK’s open innovation research into diseases affecting the developing world

GlaxoSmithKline plc (GSK) today announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world.
Source: GSK news - Category: Pharmaceuticals Source Type: news